US OptionsDetailed Quotes
CYBN241220C12500
- 0.55
- -0.50-47.62%
15min DelayClose Nov 27 16:00 ET
0.85High0.55Low
0.80Open1.05Pre Close80 Volume645 Open Interest12.50Strike Price6.27KTurnover135.69%IV27.32%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.55Extrinsic Value100Contract SizeAmericanOptions Type0.3383Delta0.1065Gamma15.77Leverage Ratio-0.0288Theta0.0017Rho5.33Eff Leverage0.0093Vega
Cybin Stock Discussion
Sign in to post a comment
$Cybin (CYBN.US)$ buying more now 🖕
1
$Cybin (CYBN.US)$👀 more news out on trials 100% effectiveness so far on the therapy drug for treating depression
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
trading under 12 now seems like something is in the works.
$Vertex Pharmaceuticals (VRTX.US)$ $Astera Labs (ALAB.US)$ $Emergent BioSolutions (EBS.US)$
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
trading under 12 now seems like something is in the works.
$Vertex Pharmaceuticals (VRTX.US)$ $Astera Labs (ALAB.US)$ $Emergent BioSolutions (EBS.US)$
$Cybin (CYBN.US)$ break the downward wedge LFG 🐂💥🚀
2
$Cybin (CYBN.US)$
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
Cybin Inc. (NYSE American:CYBN)reported groundbreaking 12-month efficacy data from its Phase 2 study of CYB003 for major depressive disorder (MDD). After two 16mg doses administered three weeks apart, 100% of participants were responsive to treatment, with 71% in remission at 12 months. The study showed a ~23-point reduction in MADRS depression s...
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
Cybin Inc. (NYSE American:CYBN)reported groundbreaking 12-month efficacy data from its Phase 2 study of CYB003 for major depressive disorder (MDD). After two 16mg doses administered three weeks apart, 100% of participants were responsive to treatment, with 71% in remission at 12 months. The study showed a ~23-point reduction in MADRS depression s...
1
$Cybin (CYBN.US)$Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year
2
$Cybin (CYBN.US)$ Redacted anyone?
2
No comment yet
DazzlerAus Shatavia Eskdrige077 : I've been following this guy for a while just be clear he is not at all positive in DTJ for longer haul he fix a post election collapse is on the cards
Mr Trecherous OP DazzlerAus :